Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and …

F Bertagna, G Biasiotto, E Orlando, G Bosio… - Japanese journal of …, 2010 - Springer
Differentiated thyroid carcinoma (DTC) is a slow-growing tumor that represents 1% of all
malignant tumors and is the most frequent endocrine cancer. 18 F-Fluorodeoxyglucose …

Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene

JD Lin, SS Fu, JY Chen, CH Lee, WK Chau, CW Cheng… - Thyroid, 2016 - liebertpub.com
Background: The association of BRAFV600E with the clinical manifestations of papillary
thyroid carcinoma (PTC) remains controversial. Recent studies have shown that the BRAF …

Relation between F-18 FDG uptake of PET/CT and BRAFV600E mutation in papillary thyroid cancer

S Yoon, YS An, SJ Lee, EY So, JH Kim, YS Chung… - Medicine, 2015 - journals.lww.com
Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mut... : Medicine Relation
Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer …

[HTML][HTML] Update on the molecular diagnosis and targeted therapy of thyroid cancer

M Liu, M Ruan, L Chen - Medical oncology, 2014 - Springer
Thyroid cancer (TC) is the most common endocrine malignancy with steadily increasing
incidence over the past few decades. Although standard strategies for the management of …

B‑Raf mutation and papillary thyroid carcinoma patients

L Jiang, H Chu, H Zheng - Oncology letters, 2016 - spandidos-publications.com
Thyroid carcinoma is the most prevalent endocrine neoplasm globally. In the majority of
thyroid carcinoma cases, a positive prognosis is predicted following administration of the …

[HTML][HTML] Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer

Z Mu, X Zhang, D Liang, J Fang, G Chen… - Chinese Journal of …, 2024 - ncbi.nlm.nih.gov
Objective Patients with radioactive iodine-refractory differentiated thyroid cancer (RAIR-
DTC) are often diagnosed with delay and constrained to limited treatment options. The …

Molecular profiling of follicular variant of papillary thyroid cancer reveals low-risk noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a …

N George, A Agarwal, N Kumari… - Indian Journal of …, 2018 - journals.lww.com
Results: All 10 NIFTPs had predominant follicular pattern. One case showed NRAS
mutation, whereas none showed BRAF mutation. All invasive EFVPTC had capsular and/or …

18F-FDG-PET/CT in patients affected by differentiated thyroid carcinoma with positive thyroglobulin level and negative 131I whole body scan. It's value confirmed by a …

F Bertagna, D Albano, G Bosio… - Current …, 2016 - ingentaconnect.com
Background: 18F-FDG-PET/CT applications in the field of differentiated thyroid cancer (DTC)
are continuously growing. Objective: To retrospectively analyze in a wide population …

A six-gene panel to label follicular adenoma, low-and high-risk follicular thyroid carcinoma

AM Poma, R Giannini, P Piaggi, C Ugolini… - Endocrine …, 2018 - ec.bioscientifica.com
The distinction between follicular thyroid carcinomas (FTCs) and follicular-patterned benign
lesions is almost impossible on fine-needle aspiration cytology. Furthermore, minimally …

Endocrine scintigraphy with hybrid SPECT/CT

KK Wong, LM Fig, E Youssef, A Ferretti… - Endocrine …, 2014 - academic.oup.com
Nuclear medicine imaging of endocrine disorders takes advantage of unique cellular
properties of endocrine organs and tissues that can be depicted by targeted …